Family history of diabetes appears to pose an increased risk of colorectal cancer in men, and this association may be partly mediated by altered sex hormones and adiponectin, according to a recent study.
Isolated or combined blood pressure (BP) elevations identified by office or ambulatory measurements are associated with a greater risk of new-onset metabolic syndrome (MetS), suggests a recent study. On the other hand, only white-coat hypertension (WCH) is linked to an increased risk of incident MetS whenever BP phenotypes are identified by office or home measurement.
Patients with chronic kidney disease appear to be at greater risk of developing type 2 diabetes mellitus (T2DM) compared with the general population, with predictors including poor baseline glycaemic control and family history of diabetes mellitus, a study has found.
Aerobic training is an effective method of reducing blood pressure and waist circumference, as well as increasing high-density lipoprotein cholesterol, in adults with metabolic syndrome, a recent meta-analysis has found.
Among obese and overweight adults with type 2 diabetes mellitus, women appear to be less likely than men to develop mild cognitive impairment, independent of traditional risk factors, a recent study has shown.
Treatment with growth hormone therapy (GHT) among childhood cancer survivors (CCSs) increases height and may improve lipid profiles and quality of life, according to the results of a systematic review and meta-analysis. In addition, GHT does not appear to increase the risk of diabetes or the development of secondary tumours.
Dietary nicotinamide riboside (NR) supplementation in 2,000-mg doses daily over a 12-week period is safe, a recent study has shown. However, it does not improve insulin sensitivity and whole-body glucose metabolism in obese, insulin-resistant men.
Long-term mild and idiopathic subclinical hypothyroidism prognosis is often benign among girls, although levothyroxine might be required during follow-up in about a quarter of cases, according to a five-year prospective study.